255
Participants
Start Date
November 21, 2019
Primary Completion Date
April 30, 2025
Study Completion Date
April 30, 2027
Orca-T
an allogeneic stem cell and T-cell immunotherapy biologic
Weill Cornell Medicine - New York-Presbyterian Hospital, New York
Memorial Sloan Kettering Cancer Center, New York
Winship Cancer Institute - Emory University, Atlanta
University of Miami Hospital and Clinics - Sylvester Comprehensive Cancer Center, Miami
Moffitt Cancer Center, Tampa
Sarah Cannon Research Institute, Nashville
Vanderbilt University, Nashville
Cleveland Clinic, Cleveland
University of Michigan Health System - Michigan Medicine, Ann Arbor
University of Chicago, Chicago
The University of Kansas Hospital, Kansas City
OU Health Stephenson Cancer Center, Oklahoma City
University of Texas MD Anderson Cancer Center, Houston
Colorado Blood Cancer Institute, Denver
University of Utah - Huntsman Cancer Institute, Salt Lake City
Ronald Reagan UCLA Medical Center, Los Angeles
City of Hope, Duarte
Stanford Health Care, Stanford
UC Davis, Sacramento
Oregon Health & Sciences University - Knight Cancer Institute, Portland
Massachusetts, Boston
Lead Sponsor
Orca Biosystems, Inc.
INDUSTRY